Literature DB >> 9756368

Sequential antibiotic therapy: the right patient, the right time and the right outcome.

P Davey1, D Nathwani.   

Abstract

The aim of sequential therapy should be to provide better quality of care at lower cost. In comparison with i.v. therapy, oral administration is safer, more acceptable to the patient, facilitates early discharge from hospital and reduces the cost of consumables. However, if given to the wrong patient, oral antimicrobial therapy could both increase the cost and reduce the quality of care, either because of ineffective treatment, or unnecessary prolongation of treatment. Hospitals must develop policies for sequential therapy which define standards against which clinical care can be audited. The standards will need to be revised as new data become available from local audit and from research. Further research on sequential therapy is undoubtedly required, with particular emphasis on the reliability of absorption of oral drugs by hospitalized patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9756368     DOI: 10.1016/s0163-4453(98)92732-3

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  5 in total

Review 1.  Addressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult Inpatients.

Authors:  Lizanne Béïque; Rosemary Zvonar
Journal:  Can J Hosp Pharm       Date:  2015 Jul-Aug

2.  Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study.

Authors:  Katherine Dunn; Audrey O'Reilly; Bernard Silke; Thomas Rogers; Colm Bergin
Journal:  Int J Clin Pharm       Date:  2011-01-25

Review 3.  Cost effectiveness of quinolones in hospitals and the community.

Authors:  P Davey
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 4.  Intravenous/oral sequential therapy in patients hospitalised with community-acquired pneumonia: which patients, when and what agents?

Authors:  Friedrich Vogel
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  The influence of a ban on outpatient intravenous antibiotic therapy among the secondary and tertiary hospitals in China.

Authors:  Xiaomin Wang; Dan Wu; Ziming Xuan; Weiyi Wang; Xudong Zhou
Journal:  BMC Public Health       Date:  2020-11-25       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.